$PXYN Praxsyn Issues Corporate Update. Financial S
Post# of 370
GlobeNewswire•March 5, 2019
LAS VEGAS, Nevada., March 05, 2019 (GLOBE NEWSWIRE) -- Praxsyn (PXYN) is pleased to provide this corporate update to all of our shareholders.
Financial Statements
Praxsyn’s management has been working to complete, and file, audited financial statements with the Securities and Exchange Commission (SEC). However, difficulties in valuing the extensive portfolio of accounts receivables generated by our wholly-owned subsidiary Mesa Pharmacy prior to 2016 made this a very arduous task. However, the process of valuing those assets is complete.
At this time, we intend to publish unaudited year end statements through December 31, 2018 with OTCMarkets.com, subject to the completion of account setup, credentialing, and requirements for public disclosures with, and of, OTCMarkets.com. While PXYN is a voluntary filer with the SEC, OTCMarkets.com has insisted that before they allow us to setup our account, we must file a Form 15 with the SEC. As OTCMarkets.com does not accept filings from reporting entities that are involuntary filers, this will confirm our status as a voluntary filer. This filing should be complete within the next 24 hours.
(continued) Praxsyn Issues Corporate Update. Financial Statements to be released. https://finance.yahoo.com/news/praxsyn-issues...soc_trk=tw via @YahooFinance